Difficult-to-treat-pediatric Crohn’s disease: focus on adalimumab

por Zeisler, Bella, Hyams, Jeffrey S
Publicado 2015

Barriers From Third-Party Payers to Biologic Use in Pediatric Inflammatory Bowel Disease

por Lepus, Chelsea A., Hyams, Jeffrey S.
Publicado 2022

Follicular Dendritic Cell Sarcoma in a Patient With Adolescent-Onset Crohn’s Disease Exposed to Multiple Immunomodulator and Biologic Therapies

por Anderson, Kaitlyn, Moss, Kerry, Campbell, Brendan, Moote, Douglas, Kakazu, Kari, Hyams, Jeffrey S.
Publicado 2022

Identification of a Pain-Specific Gene Expression Profile for Pediatric Recurrent Abdominal Pain

por Willits, Adam B., Grossi, Victoria, Glidden, Nicole C., Hyams, Jeffrey S., Young, Erin E.
Publicado 2021

Bowel Location Rather Than Disease Subtype Dominates Transcriptomic Heterogeneity in Pediatric IBD

por Venkateswaran, Suresh, Marigorta, Urko M., Denson, Lee A., Hyams, Jeffrey S., Gibson, Greg, Kugathasan, Subra
Publicado 2018

The Continental Divide: Anti-TNF Use in Pediatric IBD Is Different in North America Compared to Other Parts of the World

por Church, Peter C., Hyams, Jeffrey, Ruemmele, Frank, de Ridder, Lissy, Turner, Dan, Griffiths, Anne M.
Publicado 2018

Durability of Immunity Is Low Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1, BA.2, and BA.3 Variants After Second and Third Vaccinations in Children and Youn...

por Bellusci, Lorenza, Zahra, Fatema Tuz, Hopkins, Dena E., Salazar, Juan C., Hyams, Jeffrey S., Khurana, Surender
Publicado 2022

Profiling non-coding RNA levels with clinical classifiers in pediatric Crohn’s disease

por Pelia, Ranjit, Venkateswaran, Suresh, Matthews, Jason D., Haberman, Yael, Cutler, David J., Hyams, Jeffrey S., Denson, Lee A., Kugathasan, Subra
Publicado 2021

Characterizing the inflammatory response in esophageal mucosal biopsies in children with eosinophilic esophagitis

por Sayej, Wael N, Ménoret, Antoine, Maharjan, Anu S, Fernandez, Marina, Wang, Zhu, Balarezo, Fabiola, Hyams, Jeffrey S, Sylvester, Francisco A, Vella, Anthony T
Publicado 2016

Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn’s Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study

por Rosh, Joel R, Turner, Dan, Griffiths, Anne, Cohen, Stanley A, Jacobstein, Douglas, Adedokun, Omoniyi J, Padgett, Lakshmi, Terry, Natalie A, O’Brien, Christopher, Hyams, Jeffrey S
Publicado 2021

Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program

por Feagan, Brian G., Schreiber, Stefan, Afzali, Anita, Rieder, Florian, Hyams, Jeffrey, Kollengode, Kanthi, Pearlman, Jared, Son, Vladimir, Marta, Cecilia, Wolf, Douglas C., D'Haens, Geert G.
Publicado 2022

Gene Expression Changes Associated with Resistance to Intravenous Corticosteroid Therapy in Children with Severe Ulcerative Colitis

por Kabakchiev, Boyko, Turner, Dan, Hyams, Jeffrey, Mack, David, Leleiko, Neal, Crandall, Wallace, Markowitz, James, Otley, Anthony R., Xu, Wei, Hu, Pingzhao, Griffiths, Anne M., Silverberg, Mark S.
Publicado 2010

Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn’s Disease: Results from IMAgINE 1 and IMAgINE 2

por Ruemmele, Frank M, Rosh, Joel, Faubion, William A, Dubinsky, Marla C, Turner, Dan, Lazar, Andreas, Eichner, Samantha, Maa, Jen-Fue, Alperovich, Gabriela, Robinson, Anne M, Hyams, Jeffrey S
Publicado 2018

Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease

por Dubinsky, Marla C., Rosh, Joel, Faubion, William A., Kierkus, Jaroslaw, Ruemmele, Frank, Hyams, Jeffrey S., Eichner, Samantha, Li, Yao, Huang, Bidan, Mostafa, Nael M., Lazar, Andreas, Thakkar, Roopal B.
Publicado 2016

Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease

por Faubion, William A., Dubinsky, Marla, Ruemmele, Frank M., Escher, Johanna, Rosh, Joel, Hyams, Jeffrey S., Eichner, Samantha, Li, Yao, Reilly, Nattanan, Thakkar, Roopal B., Robinson, Anne M., Lazar, Andreas
Publicado 2017

Longitudinal DNA methylation profiling of the rectal mucosa identifies cell-specific signatures of disease status, severity and clinical outcomes in ulcerative colitis cell-specifi...

por Venkateswaran, Suresh, Somineni, Hari K., Matthews, Jason D., Kilaru, Varun, Hyams, Jeffrey S., Denson, Lee A., Kellamayer, Richard, Gibson, Greg, Cutler, David J., Conneely, Karen N., Smith, Alicia K., Kugathasan, Subra
Publicado 2023

731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS

por Dailey, Joelynn, Hyams, Jeffrey S., Hopkins, Dena, Grandonico, Kristen, Brimacombe, Michael, Lapin, Blaine, Schreiber, John, Kozhaya, Lina, Dogan, Mikail, Placek, Lindsey, Renzullo, Stephanie, Gunter, Courtney L., Salazar, Juan C., Unutmaz, Derya
Publicado 2021

Unlimited expansion of intestinal stem cells from a wide range of ages

por Duleba, Marcin, Mahalingam, Rajasekaran, Liew, Audrey-Ann, Qi, Yutao, Neupane, Rahul, Vincent, Matthew, Agarwal, Suneal, Sylvester, Francisco A, Hyams, Jeffrey S, Ho, Khek Yu, Hou, Jason K, McKeon, Frank, Xian, Wa
Publicado 2019

Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease

por Dailey, Joelynn, Kozhaya, Lina, Dogan, Mikail, Hopkins, Dena, Lapin, Blaine, Herbst, Katherine, Brimacombe, Michael, Grandonico, Kristen, Karabacak, Fatih, Schreiber, John, Liang, Bruce Tsan-Liang, Salazar, Juan C, Unutmaz, Derya, Hyams, Jeffrey S
Publicado 2021

Methylation quantitative trait loci are largely consistent across disease states in Crohn’s disease

por Venkateswaran, Suresh, Somineni, Hari K, Kilaru, Varun, Katrinli, Seyma, Prince, Jarod, Okou, David T, Hyams, Jeffrey S, Denson, Lee A, Kellermayer, Richard, Gibson, Greg, Cutler, David J, Smith, Alicia K, Kugathasan, Subra, Conneely, Karen N
Publicado 2022